Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Utility of fractional exhaled nitric oxide suppression as a prediction tool for progression to biologic therapy
Claire A. Butler, Alan J. McMichael, Kirsty Honeyford, Louise Wright, Jayne Logan, Joshua Holmes, John Busby, Catherine E. Hanratty, Freda Yang, Steven J. Smith, Kirsty Murray, Rekha Chaudhuri, Liam G. Heaney
ERJ Open Res, 7 (3) 00273-2021; 10.1183/23120541.00273-2021
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Claire A. Butler, Alan J. McMichael, Kirsty Honeyford, Louise Wright, Jayne Logan, Joshua Holmes, John Busby, Catherine E. Hanratty, Freda Yang, Steven J. Smith, Kirsty Murray, Rekha Chaudhuri, Liam G. Heaney. Utility of fractional exhaled nitric oxide suppression as a prediction tool for progression to biologic therapy. ERJ Open Res, 7 (3) 00273-2021; 10.1183/23120541.00273-2021
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Investigation on the effectiveness of the Mostgraph and fractional exhaled nitric oxide measurement in chronic cough
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Clinical utility of fractional exhaled nitric oxide in severe asthma management
Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019
Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control
Source: Annual Congress 2009 - Airway inflammation and asthma control
Is exhaled nitric oxide measurement useful in clinical practice?
Source: ISSN=ISSN 1810-6838, ISBN=, page=185
Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model
Source: Eur Respir J 2006; 28: 1236-1244
Increased levels of fractional exhaled nitric oxide after chemotherapy for lung cancer. Ongoing study
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Comparison of exhaled nitric oxide values measured by two offline methods or NO breath
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Exhaled nitric oxide as a biomarker in different COPD phenotypes
Source: International Congress 2018 – Biomarkers for evaluating COPD
Value of exhaled nitric oxide in the evaluation of disease activity in sarcoidosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 174s
The source of exhaled nitric oxide does not correlate with clinical markers in interstitial lung disease
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 677s
Extended measurement of exhaled nitric oxide in patients after lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 705s
Fractional exhaled nitric oxide (FeNO) suppression with directly observed inhaled corticosteroid therapy: does it make a difference to patient outcomes?
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Technical problems with measurements of biomarkers - exhaled nitric oxide
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance?
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control